| 英文名 | Prepro-Atrial Natriuretic Factor (56-92) (human) |
|---|---|
| 英文别名 |
PRRO-ATRIAL NATRIURETIC FACTOR (HUMAN)
H-GLU-VAL-VAL-PRO-PRO-GLN-VAL-LEU-SER-GLU-PRO-ASN-GLU-GLU-ALA-GLY-ALA-ALA-LEU-SER-PRO-LEU-PRO-GLU-VAL-PRO-PRO-TRP-THR-GLY-GLU-VAL-SER-PRO-ALA-GLN-G-OH PRRO-HANF FRAGMENT HUMAN PRRO-ANF , HUMAN PRRO-ATRIAL NATRIURETIC PTIDE, FRAGE GLU-VAL-VAL-PRO-PRO-GLN-VAL-LEU-SER-GLU-PRO-ASN-GLU-GLU-ALA-GLY-ALA-ALA-LEU-SER-PRO-LEU-PRO-GLU-VAL-PRO-PRO-TRP-THR-GLY-GLU-VAL-SER-PRO-ALA-GLN-G L-ginine, L-alpha-glutamyl-L-valyl-L-valyl-L-prolyl-L-prolyl-L-glutaminyl-L-valyl-L-leucyl-L-seryl-L-alpha-glutamyl-L-prolyl-L-aspaginyl-L-alpha-glutamyl-L-alpha-glutamyl-L-alanylglycyl-L-alanyl-L-alanyl-L-leucyl-L-seryl-L-prolyl-L-leucyl-L-prolyl-L-alpha-glutamyl-L-valyl-L-prolyl-L-prolyl-L-tryptophyl-L-threonylglycyl-L-alpha-glutamyl-L-valyl-L-seryl-L-prolyl-alanyl-L-glutaminyl ]-Human proatrioptin Prro-Atrial Natriuretic Factor (huMan) Prro-hANF (huMan) Prro-anf PRRO-ATRIAL NATRIURETIC PTIDE, FRAGMENT HUMAN N-(3-{3-[(Cyclopropylcarbonyl)amino]-7-isoquinolinyl}-4-methylphenyl)-4-[1-(dimethylamino)ethyl]benzamide L-alpha-Glutamyl-L-valyl-L-valyl-L-prolyl-L-prolyl-L-glutaminyl-L-valyl-L-leucyl-L-seryl-L-alpha-glutamyl-L-prolyl-L-aspaginyl-L-alpha-glutamyl-L-alpha-glutamyl-L-alanylglycyl-L-alanyl-L-alanyl-L-leucyl-L-seryl-L-prolyl-L-leucyl-L-prolyl-L-alpha-glutamyl-L-valyl-L-prolyl-L-prolyl-L-tryptophyl-L-threonylglycyl-L-alpha-glutamyl-L-valyl-L-seryl-L-prolyl-alanyl-L-glutaminyl-L-ginine PRRO-HANF (HUMAN) |
| 描述 | 预处理ANF(56-92),人是一种人心钠素前体。预处理ANF(56-92),人也是一种鸟苷酸环化酶激活剂,可增强肾膜和肾单位中的鸟苷酸颗粒环化酶活性[1]。 |
|---|---|
| 相关类别 | |
| 体外研究 | 预处理ANF(56-92),人(1µM;10分钟)增强105000 g全肾匀浆、肾皮质和髓质膜以及分离的远端肾单位中的颗粒鸟苷酸环化酶[1]。 |
| 参考文献 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 646.4±55.0 °C at 760 mmHg |
| 分子式 | C31H32N4O2 |
| 分子量 | 492.611 |
| 闪点 | 344.7±31.5 °C |
| 精确质量 | 492.252533 |
| LogP | 4.78 |
| 蒸汽压 | 0.0±1.9 mmHg at 25°C |
| 折射率 | 1.688 |